About Company
- Legal Name: Jiangsu Hengrui Medicine Co., Ltd.
- Registered country: China
- Address: No. 7, Kunlunshan Road,, Economic & Technological, Development Zone,, Lianyungang
- Number of employees: From 5000
Description:
Hengrui Medicine is a leading pharmaceutical company based in China focused on research, development, manufacturing and commercialization of innovative and high-quality healthcare products. Restructured into a joint-stock company in 1997 and listed on the Shanghai Stock Exchange in 2000 under stock code 600276, the company ranks among the top 30 worldwide in the pharmaceutical industry by market capitalization, exceeding 55 billion USD, with more than 21,900 employees worldwide and a leading position in cancer drugs and contrast agents.
Business Activities
Finished Dosage Forms
Manufacturer
Innovator APIs
Manufacturer
Sales Markets
- East Asia: China, Democratic People's Republic of Korea, Mongolia, Republic of Korea, Japan, Taiwan
- South Asia: Bangladesh, Bhutan, India, Maldives, Nepal, Pakistan, Sri Lanka, Afghanistan, Iran
- Mainland Southeast Asia: Cambodia, Lao People's Democratic Republic, Myanmar, Thailand, Viet Nam, Brunei Darussalam, Indonesia, Malaysia, Philippines, Timor-Leste, Singapore
- Melanesia: Papua New Guinea
- Western Asia: United Arab Emirates, Armenia, Azerbaijan
Our Products & Services
Certifications
GMP
Proofs
CPHI & PMEC China 2026
06/2026 – 06/2026
CPHI & PMEC China 2026
Ratings
(0)
(0)
(0)
(0)
(0)
Comments
Filters:
Sort by:
No comments available.
Leave your rating & comment